AI-generated summary
The authors studied photobiomodulation therapy (PBMT) in cell cultures and mice with tumors, as well as a cisplatin-treated model of muscle cachexia. They report that PBMT reduced cancer-associated muscle atrophy and that this effect involved the PI3K/AKT/FoxO3a pathway, with the protective effect blocked by an AKT inhibitor. The work is in vitro and in animals, so applicability to humans is not established.
- Who or what was studied
- Cultured myotubes, mice bearing tumors, and a cisplatin-treated mouse model of muscle cachexia
- Limits stated in the abstract
- The study was conducted in vitro and in mice, and the abstract does not report human data or the light parameters used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.